Interim FDG PET-CT in Melanoma Metastatic Patient's Treated by Anti-PD1 Therapy
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Metastatic Melanoma
Related studies linked through entity extraction aliases.
A Study to Evaluate Safety and Therapeutic Activity of RO6874281 in Combination with Pembrolizumab, in Participants with Advanced or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Low Dose Ipilimumab With Pembrolizumab in Treating Patients With Melanoma That Has Spread to the Brain
- Status
- COMPLETED
- Phase
- PHASE2
Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Radiation and Combination Immunotherapy for Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention
- Status
- COMPLETED
- Phase
- PHASE1
Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Arm 1: Lysate Pulsed Dendritic Cells (PV-001-DC) in Patients With Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1
MG1-MAGEA3 With Ad-MAGEA3 and Pembrolizumab in Patients With Previously Treated Metastatic Melanoma or Cutaneous Squamous Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Safety of AV-MEL-1 With Anti-PD-1 Therapy in Metastatic Melanoma
- Status
- RECRUITING
- Phase
- PHASE1
Evaluation of Safety and Efficacy of Patients With Four and More Symptomatic Brain Metastases of Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Nivolumab Plus Relatlimab or Ipilimumab in Metastatic Melanoma Stratified by MHC-II Expression
- Status
- TERMINATED
- Phase
- PHASE2
A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Precise DCE-MRI in Diagnosing Participants With Recurrent High Grade Glioma or Melanoma Brain Metastases
- Status
- TERMINATED
- Phase
- NA
A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)
- Status
- COMPLETED
- Phase
- PHASE2
Safety of ADU-1604 in Adults With Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Ipilumumab and Nivolumab With or Without Hypofractionated Radiotherapy in Patients With Metastatic Melanoma
- Status
- RECRUITING
- Phase
- PHASE2
Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
A Study Evaluating the Safety and Efficacy of Cobimetinib Plus Atezolizumab in BRAFV600 Wild-type Melanoma With Central Nervous System Metastases and Cobimetinib Plus Atezolizumab and Vemurafenib in BRAFV600 Mutation-positive Melanoma With Central Nervous System Metastases
- Status
- COMPLETED
- Phase
- PHASE2